All In MedTech

FDA Clearance Tracker · P200040

SoftVue™ Automated Whole Breast Ultrasound System with Sequr™ Breast Interface Assembly

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Oct 6, 2021 (this decision)Source: openFDAMethods & limitations

PMA

The decision

FDA number
P200040
Device name
SoftVue™ Automated Whole Breast Ultrasound System with Sequr™ Breast Interface Assembly
Applicant location
Novi, MI
Received
Sep 3, 2020
Decided
Oct 6, 2021
Decision
Approved
Supplements
1 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code PAA

FDA's approval statement

As written in FDA's record.

Approval for the SoftVue System. The device is indicated as an adjunct to mammography for breast cancer screening in asymptomatic women with dense breast parenchyma after confirmation that the breast density composition is BI-RADS c or d at the time of screening mammography. The device is intended to increase breast cancer detection in the described patient population relative to mammography alone. The device is not intended to be used as a replacement for screening mammography. The device can be used at the same visit as screening mammography and SoftVue images are intended to be interpreted with the mammogram results to enhance screening.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code PAA. The earliest in FDA's data is P110006, decided Sep 18, 2012.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Delphinus Medical Technologies

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.